Cancer is one of the deadliest diseases ever, and it has taken lives of millions of people across the globe and continued to spread like an epidemic. Even though medical advancements are taking place at a massive pace and have helped in finding a cure for many of the different forms of cancer, some of its forms remain irreversible. Due to some of his personal experiences in the family, Eric Lefkofsky, one of the most inspiring and successful entrepreneurs in the world, noticed that the lack of better treatment is primarily due to the lack of molecular, clinical, and genomic data with the oncologists and more information click here.
It is, for this reason, Eric Lefkofksy co-founded Tempus, which is technology based database sequencing and collection firm that would help the oncologists and doctors to get clinical, genomic, and molecular data at one place. It would help the patients get personalized treatment for cancer and help in faster recovery or to control the disease successfully. Currently, most of the cancer patients get the same kind of treatment, and sometimes it works, and sometimes it doesn’t. However, it is a known fact that with cancer, one size fits all approach isn’t highly successful, especially in the more advanced forms of cancers. The collection of data that Tempus is aiming for is probably not possible manually and Eric on Facebook.
Eric Lefkofsky has a technological background and has co-founded many successful technology-based companies such as Media Ocean, Uptake Technologies, Echo Global Logistics, and Groupon Inc. Eric Lefkofksy is putting his technical expertise at work to make Tempus successful and achieve its objectives, which can potentially transform how the cancer is treated worldwide. Eric Lefkofsky says that he is ready to invest over a hundred million dollars in the enterprise and Tempus has also received considerable funding from other venture capital firms as well and what Eric knows.
The primary objective of Tempus is to beat cancer with the help of providing the medical professionals with data that would help them pinpoint which cancer therapy is more suitable for their patients. As the genetic structure of each patient is different, the data provided by Tempus can be instrumental in finding the right treatment course and Eric’s lacrosse camp.